Daré Bioscience, Inc. (DARE)
0.814
+0.01
(+1.56%)
USD |
NASDAQ |
Aug 25, 14:44
Daré Bioscience 1 Year Total Returns (Daily) : -62.19% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -62.19% |
| August 21, 2026 | -60.96% |
| August 20, 2026 | -60.72% |
| August 19, 2026 | -59.19% |
| August 18, 2026 | -63.59% |
| August 17, 2026 | -63.17% |
| August 14, 2026 | -55.07% |
| August 13, 2026 | -35.07% |
| August 12, 2026 | -29.06% |
| August 11, 2026 | -26.90% |
| August 10, 2026 | -29.17% |
| August 07, 2026 | -31.37% |
| August 06, 2026 | -41.15% |
| August 05, 2026 | -44.17% |
| August 04, 2026 | -43.93% |
| August 03, 2026 | -47.11% |
| July 31, 2026 | -49.17% |
| July 30, 2026 | -48.01% |
| July 29, 2026 | -53.23% |
| July 28, 2026 | -53.53% |
| July 27, 2026 | -48.64% |
| July 24, 2026 | -51.33% |
| July 23, 2026 | -52.63% |
| July 22, 2026 | -53.26% |
| July 21, 2026 | -53.36% |
| Date | Value |
|---|---|
| July 20, 2026 | -46.83% |
| July 17, 2026 | -21.60% |
| July 16, 2026 | -25.95% |
| July 15, 2026 | -27.11% |
| July 14, 2026 | -33.01% |
| July 13, 2026 | -16.90% |
| July 10, 2026 | -15.48% |
| July 09, 2026 | -15.16% |
| July 08, 2026 | -15.42% |
| July 07, 2026 | -14.58% |
| July 06, 2026 | -13.33% |
| July 02, 2026 | -12.92% |
| July 01, 2026 | -10.97% |
| June 30, 2026 | -11.72% |
| June 29, 2026 | -11.21% |
| June 26, 2026 | -20.53% |
| June 25, 2026 | -24.24% |
| June 24, 2026 | -22.10% |
| June 23, 2026 | -19.14% |
| June 22, 2026 | -27.30% |
| June 18, 2026 | -25.68% |
| June 17, 2026 | -27.90% |
| June 16, 2026 | -28.96% |
| June 15, 2026 | -34.65% |
| June 12, 2026 | -35.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Nektar Therapeutics | 172.6% |
| Elite Pharmaceuticals, Inc. | -47.33% |
| Eton Pharmaceuticals, Inc. | 272.4% |
| ANI Pharmaceuticals, Inc. | -18.50% |
| Corcept Therapeutics, Inc. | 75.23% |